Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) Short Interest Update

Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) saw a significant decrease in short interest in August. As of August 14th, there was short interest totaling 11,255 shares, a decrease of 35.4% from the July 30th total of 17,416 shares. Based on an average trading volume of 30,001 shares, the short-interest ratio is presently 0.4 days. Approximately 1.2% of the company’s shares are short sold.

Cuprina Holdings (Cayman) Price Performance

NASDAQ CUPR traded down $0.01 on Tuesday, reaching $2.90. The company had a trading volume of 4,794 shares, compared to its average volume of 1,269,069. The company has a quick ratio of 2.35, a current ratio of 2.35 and a debt-to-equity ratio of 0.07. Cuprina Holdings has a 1 year low of $1.76 and a 1 year high of $19.60. The firm has a 50-day moving average of $3.87 and a 200-day moving average of $3.24.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised shares of Cuprina Holdings (Cayman) from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 26th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Cuprina Holdings (Cayman) currently has an average rating of “Sell”.

About Cuprina Holdings (Cayman)

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.